Lung adenocarcinoma (LUAD) is the most frequent subtype of lung cancer worldwide.
However, the survival rate of LUAD patients remains low. N6-methyladenosine (m 6 A) and …

Carbon-bound exogenous compounds, such as polycyclic aromatic hydrocarbons (PAHs),
tobacco-specific nitrosamines, aromatic amines, and organohalogens, are known to affect …

Background: Platelets (PLT) have a significant effect in promoting cancer progression and
hematogenous metastasis. However, the effect of platelet activation-related lncRNAs (PLT …

Introduction: Molecular chaperones and long non-coding RNAs (lncRNAs) have been
confirmed to be closely related to the occurrence and development of tumors, especially …

Diffuse large B‐cell lymphoma (DLBCL) is the most common lymphoid subtype. However,
unsatisfactory survival outcomes remain a major challenge, and the underlying mechanisms …

Background: Evidence suggests that the tumor microenvironment (TME) affects the tumor
active response to immunotherapy. Tumor angiogenesis is closely related to the TME …

Background CD86 has great potential to be a new target of immunotherapy by regulating
cancer immune response. However, it remains unclear whether CD86 is a friend or foe in …

Enhancer of zeste homolog 2 (EZH2) is an important epigenetic regulator, and is associated
with the malignant progression of lung cancer. However, the mechanisms of EZH2 on lung …

Objective: Abnormal DNA methylation can regulate carcinogenesis in lung adenocarcinoma
(LUAD), while transcription factors (TFs) mediate methylation in a site-specific manner to …

Background: There is increasing evidence that long non-coding RNAs (lncRNAs) can be
used as potential prognostic factors for cancer. This study aimed to develop a prognostic …